Market Research Logo

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Immunology), End User (Hospitals, Clinical Research Laboratories) - Global Forecast to 2021

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Immunology), End User (Hospitals, Clinical Research Laboratories) - Global Forecast to 2021

The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed to growing aging population, rising incidences of bleeding and immune disorders, and growing use of immunoglobulin and alpha-1-antitrypsin. However, the high cost of plasma products, adverse reactions associated with use of products, and limited reimbursement policies can hinder the growth of this market. Moreover, the increasing usage of recombinant coagulation factors as an alternative to plasma-derived coagulation factors is further hampering the growth of this market to a certain extent.

In this report, the plasma fractionation market is segmented on the basis of products, applications, end users, and regions. In 2015, the immunoglobulin segment accounted for the largest share of the global plasma fractionation market, by product. The large share of this segment can primarily be attributed to the rising incidences of neurological and immunological diseases, growing use of intravenous immunoglobulin (IVIg) in various therapeutic areas, and rising adoption of subcutaneous immunoglobulin (SCIg). On the basis of application, neurology segment accounted for the largest share of the plasma fractionation market. In 2015, hospitals and clinics accounted for the largest share of global plasma fractionation market, by end-user. This large share for hospitals and clinics is due to increasing use of plasma products for labeled and off-labeled use for the treatment of various diseases in hospitals and clinics. In addition, the improvement of healthcare infrastructure in hospitals and clinics in emerging countries is expected to support the growth of this segment.

Geographically, North America commanded a major share of the plasma fractionation market in 2015. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the rapid growth in the aging population, increasing use of albumin and immunoglobulin, and increasing number of hemophilic patients.

Some of the prominent players in the plasma fractionation market include CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), and Sanquin (Netherlands).

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the service portfolios offered by the top players in the plasma fractionation market. The report analyzes the plasma fractionation market by product, application, end user, and region
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new services launches in the plasma fractionation market
Market Development: Comprehensive information about the lucrative emerging markets by product and region
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the plasma fractionation market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and services, and testing capabilities of leading players in the plasma fractionation market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY SOURCES
      • PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PLASMA FRACTIONATION MARKET OVERVIEW
    • ASIA-PACIFIC PLASMA FRACTIONATION MARKET
    • PLASMA FRACTIONATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • PLASMA FRACTIONATION MARKET: GEOGRAPHIC MIX
    • PLASMA FRACTIONATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
    • KEY MARKET DRIVERS
      • GROWING USE OF IMMUNOGLOBULINS IN VARIOUS THERAPEUTIC AREAS
        • Table ON-LABEL AND OFF-LABEL INDICATIONS OF IVIG
      • RISE IN THE AGING POPULATION ACROSS THE GLOBE
      • GROWING PREVALENCE OF RESPIRATORY DISEASES AND AATD DRIVING THE UPTAKE OF ALPHA-1 ANTITRYPSIN
      • INCREASE IN PLASMA COLLECTION
        • Table GROWING USE OF IMMUNOGLOBULINS IN VARIOUS THERAPEUTIC AREAS ARE DRIVING MARKET GROWTH
    • KEY MARKET RESTRAINTS
      • HIGH COST AND LIMITED REIMBURSEMENTS
      • STRINGENT GOVERNMENT REGULATIONS
      • EMERGENCE OF RECOMBINANT ALTERNATIVES
        • Table HIGH COST AND LIMITED REIMBURSEMENTS ARE RESTRAINING MARKET GROWTH
    • KEY MARKET OPPORTUNITIES
      • INCREASING NUMBER OF HEMOPHILIC PATIENTS
        • Table INCREASING NUMBER OF HEMOPHILIC PATIENTS PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
    • KEY CHALLENGES
      • PRICING PRESSURE FACED BY PROMINENT PLAYERS IN THE MARKET
        • Table PRICING PRESSURE FACED BY PROMINENT PLAYERS IN THE MARKET IS A MAJOR MARKET CHALLENGE
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • KEY INDUSTRY TRENDS
      • FOCUS ON INCREASING FRACTIONATION CAPACITIES AND GEOGRAPHICAL EXPANSIONS
        • Table FRACTIONATION CAPACITY EXPANSION BY MAJOR PLAYERS
      • NEW INDICATIONS FOR PLASMA PRODUCTS
      • RISING ADOPTION OF SCIG
      • INCREASING NUMBER OF FRACTIONATOR-OWNED PLASMA COLLECTION CENTERS
      • GROWING PLASMA PRODUCTS MARKET IN CHINA
        • Table PER CAPITA CONSUMPTION OF IVIG AND ALBUMIN, BY COUNTRY (2012)
        • Table MAJOR LOCAL PLAYERS IN CHINA
      • INCREASING FOCUS OF PLASMA FRACTIONATORS TOWARDS MANUFACTURING AND DEVELOPMENT OF RECOMBINANT FACTORS
        • Table REGIONAL IMPACT ANALYSIS OF RECOMBINANT FACTORS ON PLASMA- DERIVED PRODUCTS
    • PORTER'S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
  • GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT
    • INTRODUCTION
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • FRACTIONATION PROCESS
    • IMMUNOGLOBULIN
      • Table GLOBAL IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL IMMUNOGLOBULIN MARKET SIZE, 2014-2021 (METRIC TONS)
      • Table GLOBAL IMMUNOGLOBULIN MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • INTRAVENOUS IMMUNOGLOBULIN
        • Table GLOBAL IVIG MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • SUBCUTANEOUS IMMUNOGLOBULIN
        • Table GLOBAL SCIG MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • OTHER IMMUNOGLOBULINS
        • Table GLOBAL OTHER IMMUNOGLOBULINS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • COAGULATION FACTOR CONCENTRATES
      • Table GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY/REGION, 2014-2021(USD MILLION)
      • FACTOR VIII
        • Table GLOBAL FACTOR VIII MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
        • Table GLOBAL FACTOR VIII MARKET SIZE, 2014-2021 ( MILLION INTERNATIONAL UNITS)
      • FACTOR IX
        • Table GLOBAL FACTOR IX MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • VON WILLEBRAND FACTOR (VWF)
        • Table GLOBAL VWF MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • PROTHROMBIN COMPLEX CONCENTRATES
        • Table GLOBAL PCC MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • FIBRINOGEN CONCENTRATES
        • Table FIBRINOGEN CONCENTRATES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • FACTOR XIII
        • Table GLOBAL FACTOR XIII MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • ALBUMIN
      • Table GLOBAL ALBUMIN MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
      • Table GLOBAL ALBUMIN MARKET SIZE, 2014-2021 (METRIC TONS)
    • PROTEASE INHIBITORS
      • Table GLOBAL PROTEASE INHIBITORS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • OTHER PLASMA PRODUCTS
      • Table GLOBAL OTHER PLASMA PRODUCTS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
    • NEUROLOGY
      • Table NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS AS PERCENTAGE OF GLOBAL DALYS (2005, 2015, &2030)
      • Table PLASMA FRACTIONATION MARKET SIZE FOR NEUROLOGY APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • IMMUNOLOGY
      • Table PLASMA FRACTIONATION MARKET SIZE FOR IMMUNOLOGY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • HEMATOLOGY
      • Table GLOBAL NUMBER OF HEMOPHILIC PATIENTS (2012-2014)
      • Table PLASMA FRACTIONATION MARKET SIZE FOR HEMATOLOGY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • CRITICAL CARE
      • Table PLASMA FRACTIONATION MARKET SIZE FOR CRITICAL CARE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • PULMONOLOGY
      • Table PLASMA FRACTIONATION MARKET SIZE FOR PULMONOLOGY APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • HEMATO-ONCOLOGY
      • Table ESTIMATED INCIDENCE AND MORTALITY RATE OF BLOOD CANCER TYPES IN DEVELOPED AND DEVELOPING COUNTRIES, BY SEX, 2012
      • Table PLASMA FRACTIONATION MARKET SIZE FOR HEMATO-ONCOLOGY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • RHEUMATOLOGY
      • Table PLASMA FRACTIONATION MARKET SIZE FOR RHEUMATOLOGY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
    • OTHER APPLICATIONS
      • Table PLASMA FRACTIONATION MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • GLOBAL PLASMA FRACTIONATION MARKET, BY END USER
    • INTRODUCTION
      • Table PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • HOSPITALS AND CLINICS
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2014-2021 (USD MILLION)
    • CLINICAL RESEARCH LABORATORIES
      • Table CLINICAL STUDIES ON ALBUMIN & IMMUNOGLOBULIN
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
    • ACADEMIC INSTITUTES
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • GLOBAL PLASMA FRACTIONATION MARKET, BY REGION
    • INTRODUCTION
      • Table GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TOTAL HEMOPHILIA PATIENTS, 2013 VS. 2014
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table DISTRIBUTION OF PRIMARY IMMUNODEFICIENCY PATIENTS IN THE U.S., 2014
        • Table PEOPLE WITH HEMOPHILIA A & HEMOPHILILA B IN U.S., 2013-2014
        • Table U.S.: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table U.S.: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table U.S.: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CANADA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table CANADA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table EUROPE: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table GERMANY: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • FRANCE
        • Table NUMBER OF PEOPLE WITH BLEEDING DISORDERS IN FRANCE : 2012-2014
        • Table FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table FRANCE: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • ITALY
        • Table PRODUCTION OF PLASMA PRODUCTS IN ITALY: 2013
        • Table ITALY: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table ITALY: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ITALY: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • SPAIN
        • Table SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table SPAIN: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.K.
        • Table USAGE OF IMMUNOGLOBULINS, 2014
        • Table ESTIMATED NO. OF HEMOPHILIA A & B PATIENTS IN THE U.K.: 2012-2014
        • Table U.K.: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table U.K.: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K.: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K.: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table U.K.: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table TOTAL HEMOPHILIA PATIENTS IN THE ROE: 2012-2014
        • Table ACCESS TO TREATMENTS FOR BLEEDING DISORDERS IN THE ROE
        • Table ROE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table ROE: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table ROE: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CHINA
        • Table CHINA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CHINA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table CHINA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2012-2021 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table CHINA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • JAPAN
        • Table JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table JAPAN: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • INDIA
        • Table NUMBER OF PATIENTS WITH BLEEDING DISORDERS: 2012-2014
        • Table INDIA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table INDIA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table INDIA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF ASIA-PACIFIC (RO-APAC)
        • Table REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table REST OF ASIA-PACIFIC: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table REST OF ASIA-PACIFIC: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table ROW: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ROW: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table ROW: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • LATIN AMERICA
        • Table ESTIMATED HEMOPHILIA PATIENTS IN BRAZIL: 2012-2014
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • MIDDLE EAST AND AFRICA
        • Table ESTIMATED HEMOPHILIA PATIENTS IN THE MIDDLE EAST AND AFRICA: 2012-2014
        • Table PER CAPITA CONSUMPTION OF FACTOR IX AND VIII (IU/TOTAL POPULATION: 2012 & 2014
        • Table MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
        • Table MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
      • Table GROWTH STRATEGY MATRIX, 2013-2016
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • EXPANSIONS
        • Table RECENT DEVELOPMENTS (2013-2016)
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013-2016)
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES (2013-2016)
      • ACQUISITIONS
        • Table ACQUISITIONS (2013-2016)
  • COMPANY PROFILES
    • INTRODUCTION
    • CSL LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GRIFOLS S.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAXALTA INCORPORATED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • OCTAPHARMA AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • KEDRION S.P.A
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LFB S.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BIOTEST AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SANQUIN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • CHINA BIOLOGIC PRODUCTS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BIO PRODUCT LABORATORY LTD. (BPL)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report